In addition, CGA supplementation (60 mg/kg/d for 12 weeks) elevated insulin sensitivity in mice with HFD-induced NAFLD, increased the abundance of Bifidobacterium and decreased the abundance of Escherichia in GM, and inhibited activation of the TLR4 signalling pathway. This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatotic liver disease.